West China Hospital Cardiac Surgery: Valve and Aortic Specialist Teams

What this department is, and what it is not

West China Hospital's cardiac and great-vessel surgery department was created in 1954 by Yang Zhenhua and Yang Jingguo. It was designated a national key discipline in 2007 and entered clinical key specialty construction in 2011. Its official overview also records a TAVI teaching base from 2017 and micro-valve intervention training from 2021, which places structured teaching and technique development alongside clinical work.

The department's scope includes valve repair and replacement, transcatheter aortic valve implantation (TAVI), coronary artery bypass grafting, aortic and congenital heart surgery, thoracoscopic atrial-fibrillation surgery and pulmonary endarterectomy. Its remit is therefore different from thoracic surgery for lung or esophageal disease. Coronary disease can involve either cardiology or cardiac surgery; an enquiry should explain whether the unresolved question concerns medical, catheter-based or surgical assessment.

For overseas patients the practical point is narrower than the department's full range. The question is not whether the hospital lists your condition, but whether its surgical team considers an operation appropriate for your anatomy, your other medical problems and your previous treatment. That judgement belongs to the treating clinicians after they see your records.

Valve work: repair, replacement and the transapical TAVI programme

Valve disease is one of the department's documented directions. The official overview lists both valve repair and valve replacement, and separately lists TAVI, so the department works across conventional open surgery and catheter-based approaches rather than offering a single route.

A 2 April 2024 official feature on the cardiac minimally invasive valve team names Guo Yingqiang, vice president and chief physician, as the team leader at that date. The same feature describes the team developing a transapical TAVI programme from 2014, alongside valve engineering work and multidisciplinary collaboration involving anaesthesia, imaging and nursing, plus operational standards and training. Read precisely, this is a dated description of a team and its programme. It does not establish that Guo currently heads the department, and it does not mean every patient is a candidate for a minimally invasive or transcatheter approach.

For a patient, the useful distinction is between repairing your own valve and replacing it, and between a surgical incision and a catheter route. Those are clinical decisions that depend on which valve is affected, how it is damaged, and what else is going on. Ask the team which options they consider realistic for you, what each involves, and what they would need to see before deciding.

Aortic disease: Hu Jia and the aortic surgery direction

The aortic side of the department is documented through Hu Jia, a chief physician, professor and doctoral supervisor who, according to the hospital's official biography, is a department deputy and director of aortic surgery. His stated clinical focus covers thoracic and abdominal aortic disease, minimally invasive, endovascular and hybrid approaches, valve repair and replacement, and ischaemic heart disease.

His research interests, as listed on the same page, include recurrent or residual aortic dissection after earlier repair, device engineering, and expert consensus work on hybrid arch procedures and haemostatic materials. A patient seeking an opinion after earlier aortic surgery can identify the previous repair and the decision still unresolved, then ask how the aortic team would assess the existing information. The biography provides a specific clinical and academic focus for that question.

The biography also lists a Chinese Medical Science Progress Third Prize, a Sichuan Medical Youth Third Prize and professional young-surgeon recognitions, without dates. These are honours recorded on an official page; they are not a statement about outcomes for any individual, and they should not be read as a ranking of the department or its surgeons.

Adult valve and congenital work: Yang Jian's documented scope

Yang Jian is listed by the hospital as professor, chief physician and master's supervisor. His official biography records former roles as an emergency deputy and a deputy in the vascular endovascular centre; those are historical positions, not current appointments, and the page does not make him a department director.

His stated clinical scope is adult valve disease with replacement and repair, adult congenital repair and closure, and aortic disease. The biography also lists a provincial science progress first prize, a provincial teaching third prize and a national teaching second prize, without dates or project details.

For an adult with a congenital heart defect who was treated years ago, or with a valve problem alongside another condition, this scope is worth noting when preparing questions. It does not tell you whether surgery is indicated now, and it does not confirm that any particular clinician will take your case. The hospital decides that after assessment.

Research, teaching and what they mean for a patient

The department's research base is described in its overview as covering aortic and congenital disease, and the overview lists a Sichuan Science Progress First Prize, a Chinese Medical Second Prize and a Sichuan Medical Third Prize without years or project names. The 2024 valve-team feature records a 2021 Sichuan Science Progress First Prize and a 2023 Sichuan Youth May 4 collective recognition, with Guo representing the team in medical research recognition.

The research themes describe different parts of surgical practice: aortic databases and recurrent-dissection work, valve-device engineering, and the training needed for a multidisciplinary program. They are useful context when asking what an assessment would address. A patient after earlier repair can ask how the previous operation would be considered; a valve patient can ask how the team would review an existing treatment proposal. Those questions require case-specific answers, not a new-device preference based on a research feature.

The 2023 Fudan national specialty reputation list placed the hospital's specialty at position 7. That is a dated historical reference for the specialty as a whole. It does not rank valve surgery above aortic surgery, does not rank individual clinicians, and is not a current 2026 ranking.

Practical questions before you plan around this department

State the established diagnosis, earlier cardiac treatment and the decision on which another opinion is sought. Ask which existing imaging or operative reports the receiving team would need, whether a records-based response is possible and what would require an in-person assessment. The hospital should confirm acceptance and arrangements before travel. Urgent deterioration needs local assessment rather than waiting for an overseas enquiry.

For a valve enquiry, ask whether the question concerns repair, replacement or an assessment of a previously proposed approach. For an aortic enquiry, identify the affected part and any earlier repair as recorded by the current team. Ask who would review the case and how the proposed opinion would be communicated, rather than treating a historic team feature as an appointment confirmation.

Heart surgery in China for international patients

Coordinating a focused cardiac-surgery enquiry

ChinaSpecialistCare can help organise a cardiac-surgery enquiry, prepare records and coordinate a visit after hospital acceptance. We are independent of the hospital and cannot guarantee a named surgeon, operation or outcome. A brief initial enquiry is free and does not require purchasing an optional proxy consultation.